Aldeyra Therapeutics (ALDX) Q1 2025 Earnings

28FebConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.28
-0.22
-0.17
-0.11

Details

Expected EPS
-0.26325
Actual EPS
-0.27
Surprise EPS
-0.01
Surprise Percent
+2.56%

Description

Aldeyra Therapeutics (ALDX) has reported earnings of -0.27 per share for Q1 2025.

0 Comments

Share your thoughts